Plasma CCL26 levels may be a useful biomarker for eCRSwNP because they are associated with NP tissue eosinophilia and plasma TSLP and IL-33 levels in patients with eCRSwNP [93]. This evidence concerns the gene CCL26 and Increased total eosinophil count.